Speeding-up Analysis and Fast-Tracking mRNA Development

mRNA therapeutics represent a cutting-edge approach for medical treatment and disease prevention. They have the potential to address a myriad of diseases, such as disorders treatable with protein replacement therapies pr targeted treatments for cancer.

Understanding the intricacies of mRNA molecules and extensive characterization is key to effective drug development. For example, it is important to comprehend transcription products and identify optimal transcription conditions and explore why these molecules may behave differently at different concentrations or buffer conditions. These processes are bottlenecks and key targets for improvement. Doing so could help speed analytical validation during mRNA drug development and bring these therapeutics to market faster.

Parallelized, multi-capillary separations can help labs screen multiple mRNA molecules under different conditions and concentrations simultaneously. With its multiplexing capability for RNA characterization, the SCIEX Biophase 8800 Capillary Electrophoresis System stands out as a solution that facilitates rapid separation and characterization of mRNA samples and allows for concurrent analysis of eight samples.

Today, mRNA technology is emerging as a pivotal tool against health crises by promising life-changing therapies. Adopting faster analytical solutions for the separation and characterization of potential molecules is paramount to hastening the development of these therapies.

Embracing innovation is crucial for foraying into the realm of mRNA-based therapeutics. At the Life Sciences companies of Danaher, we can help get to your next breakthrough faster. To partner together, contact an expert today.